BMC Medicine | 14-Jan-22

Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma

  View more

Modern Pathology | 31-May-22
Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma

 View more
Cancer Cell | 10-Jan-22

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

 View more
Journal of Clinical Oncology | 22-Feb-22

Efficacy and safety of sintilimab plus anlotinib for PD-L1-positive recurrent, or metastatic cervical cancer: a multicenter, single arm, prospective phase II trial

 View more
Nature Biotechnology | 12-Apr-21
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology

 View more

Journal of Thoracic Oncology | Mar-21

Brigatinib After Progression From Alectinib or Crizotinib: Paving the Way for Treatment Sequencing of ALK Inhibitors in ALK-Positive NSCLC

 View more
Cancer Cell | 13-Sep-21

Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): a multicenter phase 3 study

 View more
Genome Biology | 16-Apr-21

Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions

 View more
Journal for ImmunoTherapy of Cancer | 10-Dec-20
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma

 View more

Journal for ImmunoTherapy of Cancer | 10-Nov-20

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial

 View more
Advanced Science | 19-Aug-19
Circulating DNA-Based Sequencing Guided Anlotinib Therapy in Non-Small Cell Lung Cancer

 View more

The Lancet Respiratory Medicine | 12-Jul-18
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial

 View more

Annals of Oncology | 15-Jan-18
Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy

 View more